© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to September
trimethyl-lock prodrug of HCV NS5A inh.
improved bioavailability in preclinical species
from derivatization of pibrentasvir
J. Med. Chem., Sep. 3, 2020
AbbVie, North Chicago, IL
“compound 9” is an investigational prodrug of pibrentasvir (ABT-530), a key component of AbbVie’s marketed HCV combination Mavyret. Pibrentasvir (PIB) is the largest approved oral small molecule since 1983 (MW…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.